Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor

This study has been completed.

Study NCT00028002 Information provided by National Cancer Institute (NCI)

First Received: December 7, 2001 Last Updated: September 15, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)